In the move to use induced pluripotent stem cells to both repair and replace damaged bone tissue in patients, recent research by scientist Darja Marolt has helped advance the field in a major way.

Scientists at the Cancer Institute of New Jersey and the Institute for Advanced Study have identified a class of compounds--known as thiosemicarbazones--that appears in early testing to correct p53's mutation in mice. Treated with the compounds, tumors either stopped growing so quickly or shrank.

A husband and wife team of scientists at the University of Pittsburgh tested an experimental drug called YM155 in lab mice infested with the rare cancer, and found that the drug beat back tumor growth in lab mice without being toxic.

A dose of antibodies, a bone marrow transplant and treatment with pancreas growth factor helped cure late-stage Type 1 diabetes in mice, researchers have found.

Japanese researchers at the Jikei University School of Medicine, Jichi Medical University and elsewhere have taken the generation of new organs and transplantation to a whole new level. As the newspaper The Mainichi reports, the scientists grew rat kidneys from cells transplanted from mouse fetuses.